Point72 Asset Management’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.19M Buy
872,662
+645,829
+285% +$3.9M 0.01% 1684
2025
Q4
$1.19M Sell
226,833
-499,495
-69% -$1.98M ﹤0.01% 2775
2025
Q3
$3.15M Sell
726,328
-1,623,672
-69% -$2.92M 0.01% 1252
2025
Q2
$2.47M Hold
2,350,000
﹤0.01% 1215
2025
Q1
$3.03M Sell
2,350,000
-63,127
-3% -$99.6K 0.01% 1115
2024
Q4
$6.03M Hold
2,413,127
0.01% 887
2024
Q3
$9.8M Hold
2,413,127
0.02% 650
2024
Q2
$8.45M Buy
+2,413,127
New +$9.84M 0.02% 668
2023
Q4
Sell
-21,100
Closed -$139K 2948
2023
Q3
$139K Sell
21,100
-448,177
-96% -$3M ﹤0.01% 1873
2023
Q2
$3.85M Buy
+469,277
New +$3.77M 0.01% 893

Other funds holding ZURA

Point72 Asset Management's ZURA Position: Q1 2026 in Review

Point72 Asset Management increased its Zura Bio (ZURA) stake by 285% in Q1 2026, buying an estimated $3.9M and bringing the position to 872,662 shares worth $5.19M. The position accounts for 0.01% of the portfolio, ranked #1684.

Point72 Asset Management first reported a position in ZURA in Q2 2023 and has held it in 10 quarters since. The position peaked at $9.8M in Q3 2024. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Point72 Asset Management held 872,662 shares of Zura Bio worth $5.19M as of Q1 2026.
  • Point72 Asset Management bought 645,829 Zura Bio shares in Q1 2026, an estimated $3.9M.
  • Zura Bio made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1684 holding.
  • Point72 Asset Management first reported a position in Zura Bio in Q2 2023 and has held it in 10 quarters since.
  • Point72 Asset Management's Zura Bio position peaked at $9.8M in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.